000			01917na a2200229 4500
003			H12O
005			20180417112753.0
008			130622s2012 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aPérez-Regadera Gómez, José Fermín _91799 _eOncología Radioterápica
245	0	0	_aConsensus on treatment of endometrium carcinoma with brachytherapy. _h[artículo]
260			_bClinical and Translational Oncology, _c2012
300			_a14(4):263-70.
500			_aFormato Vancouver: Guinot JL, Pérez-Calatayud J, Azcoaga JM, Herruzo I, Bodineau C, Rovirosa A, et al. Consensus on treatment of endometrium carcinoma with brachytherapy. Clin Transl Oncol. 2012 Apr;14(4):263-70.
501			_aPMID: 22484633
504			_aContiene 23 referencias
520			_aRadiotherapy (RT) is commonly used as adjuvant treatment following hysterectomy and double oophorectomy in endometrial carcinoma. Prophylactic vaginal brachytherapy (BT) is the most common treatment in BT units. The PORTEC and GOG 99 studies have attempted to clarify the indications of BT and postoperative external RT, changing treatment standards. However, prophylactic BT regimens are very varied and there is currently no consensus on how to treat patients in terms of dose per fraction and number of fractions. Moreover, unoperated cases of endometrium are uncommon and there is limited experience in their treatment with BT. The 9th Consensus Meeting of the SEOR and SEFM Brachytherapy Group, held in Malaga on 11 March 2011, was therefore dedicated to "Brachytherapy in Endometrial Carcinoma". This article presents the consensus on treatment of endometrial carcinoma in operated (prophylactic vaginal BT) and unoperated (endouterine BT) patients.
710			_9302 _aServicio de Oncología Radioterápica
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/8/pc8763.pdf _ySolicitar documento
942			_n0 _2ddc _cART
999			_c8763 _d8763